Literature DB >> 8602991

Eosinophilia associated with proliferation of CD(3+)4-(8-) alpha beta+ T cells with chromosome 16 anomalies.

K Kitano1, N Ichikawa, B Mahbub, M Ueno, T Ito, S Shimodaira, H Kodaira, F Ishida, H Kobayashi, H Saito, Y Okubo, H Enokihara, K Kiyosawa.   

Abstract

We describe a patient with eosinophilia and an abnormal CD(3+)4-(8-) alpha beta+ T-cell population. Chromosomal analysis of sorted CD(3+)4-(8-) cells revealed abnormal karyotypes on chromosome 16. In the presence of IL-2 the production of IL-5 from CD(3+)4-(8-) cells was higher than that from CD(3+)4-(8-) cells. Eosinophil survival-enhancing activity in the patient serum was inhibited by a combination of anti-IL-5 and anti-GM-CSF monoclonal antibodies. These data suggest that increased production of IL-5 and GM-CSF from the abnormal CD(3+)4-(8-) cells might cause eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602991     DOI: 10.1046/j.1365-2141.1996.d01-1482.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Hypereosinophilia in a patient with invasive thymoma with clonal T-lymphocyte expansion expressing CD4, CD8, and CD25 antigens.

Authors:  Masahiko Sumi; Kosuke Nunoda; Tomonori Mizutani; Yuko Ishii; Akihiko Gotoh; Yukihiko Kimura; Yasuhiro Suga; Tatsuo Ohira; Kuniharu Miyajima; Hiromi Serizawa; Kiyoshi Mukai; Harubumi Kato; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  More than 13 years of hypereosinophila associated with clonal CD3-CD4+ lymphocytosis of TH2/TH0 type.

Authors:  Koichi Sugimoto; Kenji Tamayose; Makoto Sasaki; Takashi Danbara; Yosuke Aikawa; Hideoki Ogawa; Naotake Sato; Eiji Tashiro; Kazuo Oshimi
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

3.  Altered cytokine expression in mesenteric lymph nodes in a rat strain (Matsumoto Eosinophilic Shinshu) that spontaneously develops hypereosinophilia.

Authors:  Shin-Ichi Muto; Makoto Monnai; Yuji Okuhara; Makoto Murakami; Junji Kuroda; Tamao Ono; Kiyoshi Matsumoto
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.